Biorbis
- Company typePrivate
- Founded2023
- HeadquartersOporto, Portugal
- Headcount11–50
- GTM typeB2B
- OfferingServices
Biorbis firmographics
Firmographics- Name
- Biorbis
- Legal name
- Biorbis
- Website
- https://biorbis.com.pt
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Biorbis industry classification
Industry- Product category
- Industrial Biotechnology R&D Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling) (HLAAAJAF)
- akta.pro secondary industries
- Process Development & Tech Transfer Services (upstream/downstream) (HLAAAKAF), Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives (EUAAAIAK), Upstream Bioprocessing Systems & Equipment (cell culture/fermentation, bioreactors, feeds/media) (HLAAAJAA)
Keywords
Where Biorbis is headquartered
LocationHeadquarters
- HQ city
- Oporto
- HQ country
- Portugal
- HQ region
- Europe
Offices1 record
Markets served
Biorbis business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure
Revenue model
- R&D Partnership Services: Biorbis generates revenue through R&D partnership contracts with global companies, providing innovation services from discovery through pilot validation to commercial scale-up. Projects are structured around specific client problems and process requirements.
- Contract Manufacturing Development: As the innovation engine for Magdalena's Biochem Unit, Biorbis supports contract manufacturing organization activities for the biotech industry, including enzyme and protein ingredient development.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom project-based pricing for enterprise clients |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Biorbis product offering
Product offeringCore offering
Biorbis is an R&D and innovation lab that designs and develops high-value molecules, enzymes, and peptides for industrial biotechnology applications. The company operates as an R&D partner and innovation engine, helping global companies translate molecular discoveries into commercially viable products through precision fermentation. It serves as the dedicated R&D laboratory for Magdalena's BioChem Unit, providing end-to-end services spanning breakthrough discovery, competitive process design, pilot validation, and industrial-scale production across animal feed, pet food, aquaculture, nutrition, biochemical, and cosmetic markets.
Product overview
Biorbis is an R&D innovation lab and service provider that operates as the innovation engine for global companies and serves as the R&D partner of Magdalena's BioChem Unit. Rather than offering a discrete product suite, Biorbis provides a structured service offering across four integrated phases: Innovate (breakthrough discovery and creation), Develop (competitive process design), Scale (from concept to market-ready), and Grow (sustainable solutions delivered at scale). The company specializes in precision fermentation, working with molecules, enzymes, and peptides to create high-performing functional solutions for animal feed, pet food, aquaculture, human nutrition and wellness, biochemicals, and skin care and cosmetics markets. Biorbis bridges discovery and biomanufacturing, enabling clients to transition from lab insights to industrial-scale production.
Differentiator
Problem solved
Functional benefit
Products and services
- Innovate - Breakthrough Discovery & Creation
- Develop - Competitive Process Design
- Scale - From Concept to Market-Ready
- Grow - Sustainable Solutions Delivered at Scale
Companies that use Biorbis
Customer profileNamed customers6 records
Segments6 records
Ideal customer profiles5 records
Biorbis technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Biorbis partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Magdalena BioChem UnitcoreBiorbis is the R&D partner and innovation engine of Magdalena's BioChem Unit. Magdalena is a Guatemalan sugar producer founded in 1983, family-owned, that is diversifying from commodity sugar into precision fermentation and biomanufacturing. Biorbis serves as the dedicated R&D laboratory supporting Magdalena's strategic shift toward high-value biological manufacturing including industrial enzymes and protein ingredients.
Scale indicators1 record
Recent moves4 records
Biorbis competitors and assessment
Company assessmentOthers
- bioMérieux: bioMérieux is a major provider of in vitro diagnostics and industrial microbiology solutions. Relevant adjacent peer given the bioassay and cellular analytical work Biorbis describes, though not a direct competitor in R&D services.
- Eurofins Scientific: Eurofins is a global leader in bioanalytical testing and laboratory services across food, feed, environmental, and pharmaceutical sectors. Comparable as an analytical services provider in the same end-markets Biorbis serves, providing complementary rather than competing capabilities.
Broad incumbents
- Novozymes: Novozymes is the world's largest industrial enzyme producer with broad capabilities in precision fermentation. Comparable to Biorbis as a large-scale player in enzyme and protein ingredients, but operates at vastly greater scale across the same end-markets including animal feed and food.
- dsm-firmenich: DSM-Firmenich is a global science-based company active in nutrition, health, and beauty with significant precision fermentation capabilities. Comparable to Biorbis across multiple target end-markets (animal nutrition, human nutrition, personal care) as a large established incumbent.
Emerging players
- Codexis: Codexis engineers enzymes and proteins using directed evolution for pharmaceutical, food, and industrial applications. Comparable to Biorbis in the enzyme engineering and protein ingredient development domains, with overlap in nutraceutical and pharmaceutical customer bases.
- LanzaTech: LanzaTech uses precision fermentation (gas fermentation) to produce sustainable chemicals and fuels. Comparable to Biorbis in the renewable biochemicals space and in developing scalable industrial bioprocesses, though focused on different feedstocks.
- Twist Bioscience: Twist Bioscience provides synthetic DNA and DNA-based products enabling synthetic biology applications. Comparable as a synthetic biology platform company, though focused more on enabling tools than on end-to-end fermentation process development like Biorbis.
Direct peers
- Conagen: Conagen is a precision fermentation company developing ingredients for food, nutrition, beauty, and pharmaceutical markets through its proprietary strain engineering platform. Comparable to Biorbis in both technology (precision fermentation) and target markets (nutrition, cosmetics, biochemicals).
- Ginkgo Bioworks: Ginkgo operates a synthetic biology platform providing cell engineering and R&D services to enterprise customers across multiple end-markets including food, nutrition, and industrial biotech. Directly comparable as a B2B R&D services platform using precision fermentation to develop molecules for global brands.
- Culture Biosciences: Culture Biosciences provides fermentation process development and manufacturing services as a CDMO for biotech companies. Comparable as a B2B precision fermentation services provider helping clients scale bioprocesses from lab to commercial production.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Biorbis social profiles
Digital presenceBiorbis financial estimates
Financial estimateRevenue estimate
Valuation estimate
Biorbis leadership team
Management profileNumber of profiles
Profiles6 records
Biorbis funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Biorbis M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Biorbis
What does Biorbis do?
Biorbis is an R&D and innovation lab that designs and develops high-value molecules, enzymes, and peptides for industrial biotechnology applications. The company operates as an R&D partner and innovation engine, helping global companies translate molecular discoveries into commercially viable products through precision fermentation. It serves as the dedicated R&D laboratory for Magdalena's BioChem Unit, providing end-to-end services spanning breakthrough discovery, competitive process design, pilot validation, and industrial-scale production across animal feed, pet food, aquaculture, nutrition, biochemical, and cosmetic markets.
Is Biorbis a public or private company?
Biorbis is a private company. It is classified as corporate owned and is currently operating.
When was Biorbis founded?
Biorbis was founded in 2023. It employs 11 to 50 people.
Where is Biorbis based?
Biorbis is headquartered in Oporto, Portugal, in the Europe region.
How does Biorbis make money?
Two revenue lines are on record. R&D Partnership Services are the primary driver. The others are contract Manufacturing Development.
Who are Biorbis's main competitors?
Others on record are bioMérieux and Eurofins Scientific. Broad incumbents are Novozymes and dsm-firmenich. Emerging players are Codexis, LanzaTech and Twist Bioscience. Direct peers are Conagen, Ginkgo Bioworks and Culture Biosciences.
Does Biorbis have an API?
No public API is recorded for Biorbis.
What industry is Biorbis in?
Biorbis's product category is Industrial Biotechnology R&D Services. Its primary akta.pro industry code is HLAAAJAF, Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling), with a secondary code of HLAAAKAF, Process Development & Tech Transfer Services (upstream/downstream). Its NAICS code is 541714 and its SIC code is 8731.